These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32612058)

  • 21. Chemotherapy with gemcitabine plus cisplatin in patients with advanced biliary tract carcinoma at Chang Gung Memorial Hospital: a retrospective analysis.
    Wu CE; Hsu HC; Shen WC; Lin YC; Wang HM; Chang JW; Chen JS
    Chang Gung Med J; 2012; 35(5):420-7. PubMed ID: 23127347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Feasibility and efficacy of gemcitabine plus cisplatin combination therapy after curative resection for biliary tract cancer.
    Kainuma O; Miura F; Furukawa D; Yamamoto H; Cho A; Sano K; Nakagohri T; Asano T
    J Hepatobiliary Pancreat Sci; 2015 Nov; 22(11):789-94. PubMed ID: 26234468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of gemcitabine plus cisplatin versus capecitabine plus cisplatin as first-line chemotherapy for advanced biliary tract cancer.
    Park K; Kim KP; Park S; Chang HM
    Asia Pac J Clin Oncol; 2017 Feb; 13(1):13-20. PubMed ID: 27770489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemotherapy for biliary tract cancer: real-world experience in a single institute.
    Maeda O; Ebata T; Shimokata T; Matsuoka A; Inada-Inoue M; Morita S; Takano Y; Urakawa H; Miyai Y; Sugishita M; Mitsuma A; Ando M; Mizuno T; Nagino M; Ando Y
    Nagoya J Med Sci; 2020 Nov; 82(4):725-733. PubMed ID: 33311803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Feasibility study of gemcitabine and cisplatin combination chemotherapy for patients with refractory biliary tract cancer.
    Sasaki T; Isayama H; Nakai Y; Mizuno S; Yamamoto K; Yagioka H; Yashima Y; Kawakubo K; Kogure H; Togawa O; Matsubara S; Sasahira N; Hirano K; Tsujino T; Tada M; Omata M; Koike K
    Invest New Drugs; 2011 Dec; 29(6):1488-93. PubMed ID: 20607585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinoma.
    Thongprasert S; Napapan S; Charoentum C; Moonprakan S
    Ann Oncol; 2005 Feb; 16(2):279-81. PubMed ID: 15668284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial.
    Valle JW; Wasan H; Lopes A; Backen AC; Palmer DH; Morris K; Duggan M; Cunningham D; Anthoney DA; Corrie P; Madhusudan S; Maraveyas A; Ross PJ; Waters JS; Steward WP; Rees C; Beare S; Dive C; Bridgewater JA
    Lancet Oncol; 2015 Aug; 16(8):967-78. PubMed ID: 26179201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biweekly cisplatin and gemcitabine in patients with advanced biliary tract cancer.
    Ahn DH; Reardon J; Ahn CW; Bupathi M; Mikhail S; Wu CS; Bekaii-Saab T
    Int J Cancer; 2018 Apr; 142(8):1671-1675. PubMed ID: 29114851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of biliary drainage on chemotherapy in patients with biliary tract cancer: an exploratory analysis of the BT22 study.
    Fukutomi A; Furuse J; Okusaka T; Miyazaki M; Taketsuna M; Koshiji M; Nimura Y
    HPB (Oxford); 2012 Apr; 14(4):221-7. PubMed ID: 22404259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase I and Biomarker Study of the Wnt Pathway Modulator DKN-01 in Combination with Gemcitabine/Cisplatin in Advanced Biliary Tract Cancer.
    Goyal L; Sirard C; Schrag M; Kagey MH; Eads JR; Stein S; El-Khoueiry AB; Manji GA; Abrams TA; Khorana AA; Miksad R; Mahalingam D; Zhu AX; Duda DG
    Clin Cancer Res; 2020 Dec; 26(23):6158-6167. PubMed ID: 32878766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive factors of the treatment outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy.
    Suzuki Y; Kan M; Kimura G; Umemoto K; Watanabe K; Sasaki M; Takahashi H; Hashimoto Y; Imaoka H; Ohno I; Mitsunaga S; Ikeda M
    J Gastroenterol; 2019 Mar; 54(3):281-290. PubMed ID: 30298469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and Feasibility of Adjuvant Gemcitabine Plus Cisplatin Chemotherapy After Major Hepatectomy for Biliary Tract Cancer.
    Mori S; Aoki T; Shiraki T; Shimizu T; Yamaguchi T; Park KH; Matsumoto T; Sakuraoka Y; Iso Y; Kubota K
    Anticancer Res; 2021 Oct; 41(10):5231-5240. PubMed ID: 34593476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase I clinical trial of oral administration of S-1 in combination with intravenous gemcitabine and cisplatin in patients with advanced biliary tract cancer.
    Shoji H; Morizane C; Sakamoto Y; Kondo S; Ueno H; Takahashi H; Ohno I; Shimizu S; Mitsunaga S; Ikeda M; Okusaka T
    Jpn J Clin Oncol; 2016 Feb; 46(2):132-7. PubMed ID: 26685318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase 2 study of copanlisib in combination with gemcitabine and cisplatin in advanced biliary tract cancers.
    Tan ES; Cao B; Kim J; Al-Toubah TE; Mehta R; Centeno BA; Kim RD
    Cancer; 2021 Apr; 127(8):1293-1300. PubMed ID: 33289918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and biomarker analysis of nivolumab plus gemcitabine and cisplatin in patients with unresectable or metastatic biliary tract cancers: results from a phase II study.
    Feng K; Liu Y; Zhao Y; Yang Q; Dong L; Liu J; Li X; Zhao Z; Mei Q; Han W
    J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32487569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Downsizing Chemotherapy for Initially Unresectable Locally Advanced Biliary Tract Cancer Patients Treated with Gemcitabine Plus Cisplatin Combination Therapy Followed by Radical Surgery.
    Kato A; Shimizu H; Ohtsuka M; Yoshitomi H; Furukawa K; Takayashiki T; Nakadai E; Kishimoto T; Nakatani Y; Yoshidome H; Miyazaki M
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1093-9. PubMed ID: 26240009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemotherapy for biliary tract cancer in Japan.
    Okusaka T
    Semin Oncol; 2002 Dec; 29(6 Suppl 20):51-3. PubMed ID: 12577234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment Outcomes of Gemcitabine and Cisplatin Combination Therapy for Unresectable and Recurrent Biliary Tract Cancer].
    Sakamoto T; Takeda Y; Ohmura Y; Katsura Y; Mori R; Nose Y; Kawai K; Murakami K; Naito A; Inatome J; Kagawa Y; Masuzawa T; Takeno A; Egawa C; Murata K
    Gan To Kagaku Ryoho; 2018 Dec; 45(13):2414-2416. PubMed ID: 30692482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cisplatin/gemcitabine or oxaliplatin/gemcitabine in the treatment of advanced biliary tract cancer: a systematic review.
    Fiteni F; Nguyen T; Vernerey D; Paillard MJ; Kim S; Demarchi M; Fein F; Borg C; Bonnetain F; Pivot X
    Cancer Med; 2014 Dec; 3(6):1502-11. PubMed ID: 25111859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NUC-1031/cisplatin versus gemcitabine/cisplatin in untreated locally advanced/metastatic biliary tract cancer (NuTide:121).
    McNamara MG; Goyal L; Doherty M; Springfeld C; Cosgrove D; Sjoquist KM; Park JO; Verdaguer H; Braconi C; Ross PJ; Gramont A; Zalcberg JR; Palmer DH; Valle JW; Knox JJ
    Future Oncol; 2020 Jun; 16(16):1069-1081. PubMed ID: 32374623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.